HENGBING WANG
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology UKIAH, CA NPI 1497940191
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA Lilly USA, LLC All categories
General Payments — all program years on this page
$7,274.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 282
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $924.10 across 41 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $863.68 | 40 |
| Education | $60.42 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $163.12 | 5 |
| E.R. Squibb & Sons, L.L.C. | $138.66 | 6 |
| Acerta Pharma LLC | $95.03 | 4 |
| Daiichi Sankyo Inc. | $81.47 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $66.02 | 3 |
| Myriad Genetic Laboratories, Inc. | $51.65 | 1 |
| Genentech USA, Inc. | $43.80 | 2 |
| Regeneron Healthcare Solutions, Inc. | $34.74 | 2 |
| Pharmacosmos Therapeutics Inc. | $33.46 | 2 |
| Janssen Biotech, Inc. | $33.24 | 2 |
| PFIZER INC. | $32.51 | 2 |
| GENZYME CORPORATION | $29.18 | 1 |
| Incyte Corporation | $23.78 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.93 | 1 |
| Merck Sharp & Dohme Corporation | $18.87 | 1 |
| Astellas Pharma US Inc | $18.22 | 1 |
| EISAI INC. | $15.14 | 1 |
| Celgene Corporation | $14.70 | 1 |
| Rigel Pharmaceuticals, Inc. | $7.58 | 1 |
By program year
Records — PY2024 (41)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.